Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48

European Heart Journal

Volumn 35, Issue 22, 2014, Pages 1457-1465

  Gupta, Deepak K ^a   Shah, Amil M ^a   Giugliano, Robert P ^a   Ruff, Christian T ^a   Antman, Elliott M ^a   Grip, Laura T ^a   Deenadayalu, Naveen ^a   Hoffman, Elaine ^a   Patel, Indravadan ^b   Shi, Minggao ^b   Mercuri, Michele ^b   Mitrovic, Veselin ^c   Braunwald, Eugene ^a   Solomon, Scott D ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DAIICHI SANKYO INC   (United States)

^c KERCKHOFF HEART CENTER   (Germany)

Author keywords

Atrial fibrillation; Echocardiography; ENGAGE AF TIMI 48; Left atrium; Stroke

Indexed keywords

EDOXABAN; ANTICOAGULANT AGENT; PYRIDINE DERIVATIVE; THIAZOLE DERIVATIVE;

AGED; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CHADS2 SCORE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE REDUCTION; DRUG MEGADOSE; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FUNCTION; HEART LEFT ATRIUM; HUMAN; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PAROXYSMAL HEART ATRIUM FIBRILLATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM; ATRIAL FIBRILLATION; CLINICAL TRIAL; HEART ATRIUM; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSPECTIVE STUDY;

AGED; ANTICOAGULANTS; ATRIAL FIBRILLATION; ATRIAL FUNCTION, LEFT; DOUBLE-BLIND METHOD; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIA; HUMANS; MALE; PROSPECTIVE STUDIES; PYRIDINES; STROKE VOLUME; THIAZOLES; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 84902277579     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/eht500     Document Type: Article

References (41)

1. Lip GY, Tse HF, Lane DA. Atrial fibrillation. Lancet 2012;379:648-661
2. Stulak JM, Dearani JA, Sundt TM III, Daly RC, Schaff HV. Ablation of atrial fibrillation: Comparison of catheter-based techniques and the Cox-Maze III operation. Ann Thorac Surg 2011;91:1882-1888; discussion 1888-9
3. Dogliotti A, Paolasso E, Giugliano RP. Novel oral anticoagulants in atrial fibrillation: A meta-Analysis of large, randomized, controlled trials vs warfarin. Clin Cardiol 2013; 36:61-67
4. Dittrich HC, Pearce LA, Asinger RW, McBride R, Webel R, Zabalgoitia M, Pennock GD, Safford RE, Rothbart RM, Halperin JL, Hart RG. Left atrial diameter in nonvalvular atrial fibrillation: An echocardiographic study. Stroke Prevention in Atrial Fibrillation Investigators. Am Heart J 1999;137:494-499. (Pubitemid 29124118
5. Gage BF,Waterman AD, ShannonW, Boechler M, RichMW, Radford MJ. Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-2870
6. Echocardiographic predictors of stroke in patients with atrial fibrillation: A prospective study of 1066 patients from three clinical trials. Arch Intern Med 1998; 158:1316-1320
7. Olshansky B, Heller EN, Mitchell LB, Chandler M, SlaterW, Green M, Brodsky M, Barrell P, Greene HL. Are transthoracic echocardiographic parameters associated with atrial fibrillation recurrence or stroke?. Results from the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) study. J Am Coll Cardiol 2005;45:2026-2033. (Pubitemid 40814127
8. Kojima T, Kawasaki M, Tanaka R, Ono K, Hirose T, Iwama M,Watanabe T, Noda T, Watanabe S, Takemura G, Minatoguchi S. Left atrial global and regional function in patients with paroxysmal atrial fibrillation has already been impaired before enlargement of left atrium: Velocity vector imaging echocardiography study. Eur Heart J Cardiovasc Imaging 2012;13:227-234
9. Gupta S, Matulevicius SA, Ayers CR, Berry JD, Patel PC, MarkhamDW, Levine BD, Chin KM, de Lemos JA, Peshock RM, Drazner MH. Left atrial structure and function and clinical outcomes in the general population. Eur Heart J 2013;34:278-285
10. Abhayaratna WP, Fatema K, Barnes ME, Seward JB, Gersh BJ, Bailey KR, Casaclang-Verzosa G, Tsang TS. Left atrial reservoir function as a potent marker for first atrial fibrillation or flutter in persons . or 65 years of age. Am J Cardiol 2008;101:1626-1629
11. Ruff CT, Giugliano RP, Antman EM, Crugnale SE, Bocanegra T, Mercuri M, Hanyok J, Patel I, Shi M, Salazar D, McCabe CH, Braunwald E. Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation-Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF-TIMI 48). Am Heart J 2010;160:635-641
12. Solomon SD, Foster E, Bourgoun M, Shah A, Viloria E, Brown MW, Hall WJ, Pfeffer MA, Moss AJ. Effect of cardiac resynchronization therapy on reverse remodeling and relation to outcome: Multicenter automatic defibrillator implantation trial: Cardiac resynchronization therapy. Circulation 2010;122:985-992
13. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, RomanMJ,Seward J, Shanewise JS, Solomon SD, SpencerKT, Sutton MS, Stewart WJ. Recommendations for chamber quantification: A report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-1463. (Pubitemid 41821197
14. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, Waggoner AD, Flachskampf FA, Pellikka PA, Evangelista A. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009;22:107-133
15. AbhayaratnaWP, Seward JB, AppletonCP, Douglas PS,OhJK, Tajik AJ, Tsang TS. Left atrial size: Physiologic determinants and clinical applications. J Am Coll Cardiol 2006; 47:2357-2363. (Pubitemid 43866385
16. Gutman J,Wang YS,Wahr D, Schiller NB. Normal left atrial function Determined by 2-dimensional echocardiography. Am J Cardiol 1983;51:336-340. (Pubitemid 13179407
17. Wang M, YipGW,Wang AY, Zhang Y, Ho PY, Tse MK, Lam PK, Sanderson JE. Peak early diastolic mitral annulus velocity by tissue Doppler imaging adds independent and incremental prognostic value. J Am Coll Cardiol 2003;41:820-826. (Pubitemid 36308391
18. Fuster V, Ryden LE, Cannom DS, Crijns HJ, Curtis AB, Ellenbogen KA, Halperin JL, Le Heuzey JY, Kay GN, Lowe JE, Olsson SB, Prystowsky EN, Tamargo JL, Wann S, Smith SC Jr, Jacobs AK, Adams CD, Anderson JL, Antman EM, Hunt SA, Nishimura R, Ornato JP, Page RL, Riegel B, Priori SG, Blanc JJ, Budaj A, Camm AJ, Dean V, Deckers JW, Despres C, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Zamorano JL. ACC/AHA/ESC 2006 Guidelines for the Management of Patients with Atrial Fibrillation: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Revise the 2001 Guidelines for the Management of Patients With Atrial Fibrillation): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 2006;114:e257-e354. (Pubitemid 44252297
19. Cuzick J. A Wilcoxon-Type test for trend. Stat Med 1985;4:87-90. (Pubitemid 15142530
20. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation. Chest 2010;137: 263-272
21. Comparison of 12 risk stratification schemes to predict stroke in patients with nonvalvular atrial fibrillation. Stroke 2008;39:1901-1910
22. Shih JY, Tsai WC, Huang YY, LiuYW, Lin CC, Huang YS, Tsai LM, Lin LJ. Association of decreased left atrial strain and strain rate with stroke in chronic atrial fibrillation. J Am Soc Echocardiogr 2011;24:513-519
23. Park JH, Joung B, Son NH, Shim JM, Lee MH, Hwang C, Pak HN. The electroanatomical remodelling of the left atrium is related to CHADS2/CHA2DS2VASc score and events of stroke in patients with atrial fibrillation. Europace 2011;13:1541-1549
24. Blume GG, McLeod CJ, Barnes ME, Seward JB, Pellikka PA, Bastiansen PM, Tsang TS. Left atrial function: Physiology, assessment, and clinical implications. Eur J Echocardiogr 2011;12:421-430
25. Marchese P, Bursi F, Delle Donne G, Malavasi V, Casali E, Barbieri A, Melandri F, Modena MG. Indexed left atrial volume predicts the recurrence of non-valvular atrial fibrillation after successful cardioversion. Eur J Echocardiogr 2011;12:214-221
26. den Uijl DW, Delgado V, Bertini M, Tops LF, Trines SA, van De Veire NR, Zeppenfeld K, Schalij MJ, Bax JJ. Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation. Heart 2011;97:1847-1851
27. Matsuo S, Lellouche N, Wright M, Bevilacqua M, Knecht S, Nault I, Lim KT, Arantes L, O'Neill MD, Platonov PG, Carlson J, Sacher F, Hocini M, Jais P, Haissaguerre M. Clinical predictors of termination and clinical outcome of catheter ablation for persistent atrial fibrillation. J Am Coll Cardiol 2009;54:788-795
28. Schneider C, Malisius R, Krause K, Lampe F, Bahlmann E, Boczor S, Antz M, Ernst S, Kuck KH. Strain rate imaging for functional quantification of the left atrium: Atrial deformation predicts the maintenance of sinus rhythm after catheter ablation of atrial fibrillation. Eur Heart J 2008;29:1397-1409. (Pubitemid 351806490
29. Risk factors for stroke and efficacy of antithrombotic therapy in atrial fibrillation. Analysis of pooled data from five randomized controlled trials. Arch Intern Med 1994;154:1449-1457
30. Flaker G, Ezekowitz M, Yusuf S, Wallentin L, Noack H, Brueckmann M, Reilly P, Hohnloser SH, Connolly S. Efficacy and safety of dabigatran compared to warfarin in patients with paroxysmal, persistent, and permanent atrial fibrillation: Results from the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Therapy) study. J Am Coll Cardiol 2012;59:854-855
31. Banerjee A, Taillandier S, Olesen JB, Lane DA, Lallemand B, Lip GY, Fauchier L. Pattern of atrial fibrillation and risk of outcomes: The Loire Valley Atrial Fibrillation Project. Int J Cardiol 2013;167:2682-2687
32. Hohnloser SH, Pajitnev D, Pogue J, Healey JS, Pfeffer MA, Yusuf S, Connolly SJ. Incidence of stroke in paroxysmal versus sustained atrial fibrillation in patients taking oral anticoagulation or combined antiplatelet therapy: An ACTIVE W Substudy. J Am Coll Cardiol 2007;50:2156-2161. (Pubitemid 350123679
33. Hart RG, Pearce LA, Rothbart RM, McAnulty JH, Asinger RW, Halperin JL. Stroke with intermittent atrial fibrillation: Incidence and predictors during aspirin therapy. Stroke Prevention in Atrial Fibrillation Investigators. J Am Coll Cardiol 2000;35: 183-187. (Pubitemid 30061278
34. The Boston Area Anticoagulation Trial for Atrial Fibrillation Investigators. The effect of low-dose warfarin on the risk of stroke in patients with nonrheumatic atrial fibrillation. N Engl J Med 1990;323:1505-1511
35. Manning WJ, Leeman DE, Gotch PJ, Come PC. Pulsed Doppler evaluation of atrial mechanical function after electrical cardioversion of atrial fibrillation. J Am Coll Cardiol 1989;13:617-623. (Pubitemid 19073928
36. Henein M, Zhao Y, Henein MY, Lindqvist P. Disturbed left atrial mechanical function in paroxysmal atrial fibrillation: A speckle tracking study. Int J Cardiol 2012;155: 437-441
37. Watson T, Shantsila E, Lip GY. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. Lancet 2009;373:155-166
38. Boyd AC, McKay T, Nasibi S, Richards DA, Thomas L. Left ventricular mass predicts left atrial appendage thrombus in persistent atrial fibrillation. Eur Heart J Cardiovasc Imaging 2013;14:269-275
39. Benjamin EJ, D'Agostino RB, Belanger AJ,Wolf PA, Levy D. Left atrial size and the risk of stroke and death. The Framingham Heart Study. Circulation 1995;92:835-841
40. Chiang CE, Naditch-Brule L, Murin J, Goethals M, Inoue H, O'Neill J, Silva-Cardoso J, Zharinov O, Gamra H, Alam S, Ponikowski P, LewalterT, Rosenqvist M, Steg PG. Distribution and risk profile of paroxysmal, persistent, and permanent atrial fibrillation in routine clinical practice: Insight from the real-life global survey evaluating patients with atrial fibrillation international registry. Circ Arrhythm Electrophysiol 2012;5: 632-639
41. Nieuwlaat R, Prins MH, Le Heuzey JY, Vardas PE, Aliot E, Santini M, Cobbe SM, Widdershoven JW, Baur LH, Levy S, Crijns HJ. Prognosis, disease progression, and treatment of atrial fibrillation patients during 1 year: Follow-up of the Euro Heart Survey on atrial fibrillation. Eur Heart J 2008;29:1181-1189. (Pubitemid 351844895.